| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A023QRK5 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| A4D2L9 | Hypothetical gene supported by AK024371; BC037920; | LOC401365; | NULL | 105 | human |
| A0A059RJY0 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| X6RK58 | Leucine-rich repeat-containing protein 20; Fragment; | LRRC20; | NULL | 175 | human |
| A0A024RD95 | Serine peptidase inhibitor, Kazal type 2 (Acrosin-trypsin inhibitor), isoform CRA_b; | SPINK2; | NULL | 84 | human |
| A4FU11 | RPS4Y1 protein; Fragment; | RPS4Y1; | NULL | 262 | human |
| H0Y552 | TBC1 domain family member 8B; Fragment; | TBC1D8B; | NULL | 218 | human |
| A4FUT7 | NAV1 protein; Fragment; | NAV1; | NULL | 113 | human |
| A8K6R9 | cDNA FLJ76718; | NULL | NULL | 742 | human |
| A0A024RD72 | Chromosome 6 open reading frame 141, isoform CRA_a; | C6orf141; | NULL | 244 | human |
| A7LFK9 | Carcinoembryonic antigen-related cell adhesion molecule 20 variant 4L; | CEACAM20; | NP_001096069.2; | 503 | human |
| H0Y4K0 | Ubiquitin carboxyl-terminal hydrolase isozyme L5; Fragment; | UCHL5; | NULL | 99 | human |
| A2JNH3 | MLL/GAS7 fusion protein; Fragment; | MLL/GAS7; | NULL | 270 | human |
| H0YCR0 | Nuclear pore complex protein Nup98-Nup96; Fragment; | NUP98; | NULL | 179 | human |
| A0A059RQV5 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 115 | human |
| E5RFI1 | Transcription elongation factor A protein 1; | TCEA1; | NULL | 47 | human |
| H3BMY9 | G-protein-coupled receptor 56; Fragment; | GPR56; | NULL | 146 | human |
| Q3B833 | IGF1R protein; Fragment; | IGF1R; | NULL | 173 | human |
| A2VCR0 | MAPRE1 protein; Fragment; | MAPRE1; | NULL | 173 | human |
| A2BCY3 | MHC class I antigen; Fragment; | HLA-C; | NULL | 181 | human |
